Press Release Belite Bio Announces U.S. Food and Drug Administration Acceptance and Priority Review of New Drug Application for Tinlarebant for the Treatment of Stargardt Disease Type 1 3 hours ago
Press Release Belite Bio to Host Webcast on August 13, 2026, to Discuss Second Quarter 2026 Financial Results Aug 6